eletriptan / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eletriptan / Generic mfg.
NCT01276977: Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine

Completed
N/A
80
US
Zolmitriptan 5 mg Nasal Spray, Eletriptan 40 mg tablet
California Medical Clinic for Headache
Acute Migraine, Migraine Headache, Headache Disorders
12/10
12/10
NCT01435941: Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine

Completed
N/A
11249
NA
Non-steroidal anti-inflammatory drug (NSAID), Triptan, Amerge® is a registered trademark of GlaxoSmithKline, Zomig® is a registered trademark of AstraZeneca, Relpax® is a registered trademark of Pfizer, Inc., Maxalt® is a registered trademark of Merck & Co, Axert® is a registered trademark of Pharmacia, Frova® is a registered trademark of Elan Pharmaceuticals/UCB Pharma, Inc, Imitrex® is a registered trademark of GlaxoSmithKline
GlaxoSmithKline
Migraine Disorders
02/11
02/11
NCT01381523: A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data

Completed
N/A
1
US
Combination therapy with sumatriptan and naproxen sodium (SumaRT/Nap), Treximet® is a registered trademark of GlaxoSmithKline, Single-entity oral triptans, Zomig® is a registered trademark of AstraZeneca, Maxalt® is a registered trademark of Merck & Co, Inc, Relpax® is a registered trademark of Pfizer, Frova® is a registered trademark of Elan Pharmaceuticals/UCB Pharma, Amerge® is a registered trademark of GlaxoSmithKline, Axert® is a registered trademark of Pharmacia, Imitrex® is a registered trademark of GlaxoSmithKline
GlaxoSmithKline
Migraine Disorders
06/11
06/11
NCT01381497: Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy

Completed
N/A
1
US
Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap), Treximet®, Triptan monotherapy, Zomig® is a registered trademark of AstraZeneca, Amerge® is a registered trademark of GlaxoSmithKline, Axert® is a registered trademark of Pharmacia, Frova® is a registered trademark of Elan Pharmaceuticals/UCB Pharma, Inc, Maxalt® is a registered trademark of Merck & Co, Imitrex® is a registered trademark of GlaxoSmithKline, Relpax® is a registered trademark of Pfizer
GlaxoSmithKline
Migraine Disorders
10/11
10/11

Download Options